ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

Cancer Care Act Introduced In Senate.

April 18, 2008

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002